Cargando…

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness

PURPOSE: Coronavirus disease 2019 (COVID-19) has highlighted the need for new methods of pharmacovigilance. Here, we use adult community volunteers to obtain systematic information on vaccine effectiveness and the nature and severity of breakthrough infections. METHODS: Between December 15, 2020 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynolds, Matthew W, Xie, Yiqiong, Knuth, Kendall B, Mack, Christina D, Brinkley, Emma, Toovey, Stephen, Dreyer, Nancy A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451035/ https://www.ncbi.nlm.nih.gov/pubmed/36090603 http://dx.doi.org/10.2147/IDR.S373183

Ejemplares similares

Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry
por: Largent, Joan, et al.
Publicado: (2023)

Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design
por: Reynolds, Matthew W, et al.
Publicado: (2022)

How frequent are acute reactions to COVID-19 vaccination and who is at risk?
por: Dreyer, Nancy, et al.
Publicado: (2022)

Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis
por: Dreyer, Nancy A., et al.
Publicado: (2020)

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness [Corrigendum]
Publicado: (2022)

Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
por: Dreyer, Nancy, et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice
por: Dreyer, Nancy A, et al.
Publicado: (2023)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Protective Effect of Neonatal Hepatitis B Vaccine Against HBV Breakthrough Infection in Children with Leukemia: A Real-world Study
por: Yang, Yuting, et al.
Publicado: (2022)

Vaccines in Breast Cancer: Challenges and Breakthroughs
por: Fatima, Gul Naz, et al.
Publicado: (2023)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
por: Stevens, Christina W., et al.
Publicado: (2023)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data
por: Perrella, Alessandro, et al.
Publicado: (2022)

Considerations when evaluating real‐world data quality in the context of fitness for purpose
por: Reynolds, Matthew W., et al.
Publicado: (2020)

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative
por: Song, Qianqian, et al.
Publicado: (2022)

Breakthrough infections in MPN-COVID vaccinated patients
por: Barbui, Tiziano, et al.
Publicado: (2022)

Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan
por: Naito, Toshio, et al.
Publicado: (2021)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance
por: Chen, Jiahui, et al.
Publicado: (2021)

Human Infection with Avian Influenza Virus, Pakistan, 2007
por: Zaman, Mukhtiar, et al.
Publicado: (2011)

Trial designs using real‐world data: The changing landscape of the regulatory approval process
por: Baumfeld Andre, Elodie, et al.
Publicado: (2019)

Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
por: Igarashi, Yuka, et al.
Publicado: (2020)

TBE Vaccination Breakthrough Cases—Does Age Matter?
por: Schmitt, Heinz-J., et al.
Publicado: (2021)

Metabolic disorders, COVID-19 and vaccine-breakthrough infections
por: Stefan, Norbert
Publicado: (2021)

COVID-19 vaccination and breakthrough infections in patients with cancer
por: Schmidt, A.L., et al.
Publicado: (2022)

The “identikit” of subject with obesity and COVID-19 vaccine breakthrough
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

COVID Infections Breakthrough Post-Vaccination: Systematic Review
por: Ali, Syed Amaan, et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Post-vaccination serum cytokines levels correlate with breakthrough influenza infections
por: Tang, Weichun, et al.
Publicado: (2023)

Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
por: Weng, Nan-ping, et al.
Publicado: (2021)

Evaluating COVID-19 vaccines in the real world
por: Mills, Edward J, et al.
Publicado: (2022)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

Vaccine Breakthrough Severe COVID-19 in a Lung Recipient
por: Beyoglu, Muhammet Ali, et al.
Publicado: (2022)

VACCINATED WITH A TWIST: BREAKTHROUGH COVID-19 IN AN IMMUNOCOMPROMISED PATIENT
por: DAOUD, DANA, et al.
Publicado: (2021)

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
por: Bergwerk, Moriah, et al.
Publicado: (2021)

Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
por: Estofolete, Cassia Fernanda, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2nbcl69ciiorc26ch1dodvlbhr